Multicenter phase II trial of motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer

Martin J. Edelman, Gregory Otterson, Joseph Leach, Thomas Malpass, Ravi Salgia, Dennie Jones, Tarak D. Mody, Ramaswamy Govindan

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Multicenter phase II trial of motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences